Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,293 public trials 1,198 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma

NCT00667082

Conditions
Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, Bronchogenic, +40 more
Locations
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • The Queen Elizabeth Hospital Woodville South, South Australia, Australia
  • Sir Charles Gairdner Hospital and University of Western Australia Nedlands, Western Australia, Australia
View Trial Details
Completed

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors

NCT00619424

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Buffalo, New York, United States
  • GSK Investigational Site Nashville, Tennessee, United States
  • GSK Investigational Site Orbassano (TO), Piedmont, Italy
View Trial Details
Completed

A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase

NCT00528281

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • GSK Investigational Site Heidelberg, Baden-Wurttemberg, Germany
  • GSK Investigational Site Großhansdorf, Schleswig-Holstein, Germany
  • GSK Investigational Site Orbassano (TO), Piedmont, Italy
  • GSK Investigational Site Poznan, Poland
View Trial Details
Completed

A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors

NCT00259935

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, Small Cell, +8 more
Locations
  • GSK Investigational Site Lebanon, New Hampshire, United States
  • GSK Investigational Site The Bronx, New York, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
  • GSK Investigational Site Nashville, Tennessee, United States
View Trial Details

Related conditions